Last update 31 May 2025

ET-02

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
CD19-UCART - EdiGene, ET 02, ET-02
+ [3]
Target
CD19
Action
inhibitors
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Lymphoblastic LeukemiaB-Cell Malignant NeoplasmNon-Hodgkin Lymphoma
Originator Organization
EdiGene Inc.EdiGene Inc.
Active Organization-
Inactive Organization
Beijing Imunopharm Technology Co., Ltd.Beijing Imunopharm Technology Co., Ltd.
EdiGene (GuangZhou) Inc.
License Organization-
Drug Highest PhaseDiscontinuedClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with ET-02
NCT04933825
/ Unknown statusNot Applicable
An Exploratory,Open-label,and Single Center Study to Evaluate the Safety and Efficacy of ET-02 in Patients With Relapsed or Refractory B-cell Malignancies(NHL/ALL).
100 Clinical Results associated with ET-02
Login to view more data
100 Translational Medicine associated with ET-02
Login to view more data
100 Patents (Medical) associated with ET-02
Login to view more data
100 Deals associated with ET-02
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaClinical
China
EdiGene (GuangZhou) Inc.
20 Jul 2021
B-Cell Malignant NeoplasmClinical
China
EdiGene (GuangZhou) Inc.
20 Jul 2021
Non-Hodgkin LymphomaClinical
China
EdiGene (GuangZhou) Inc.
20 Jul 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free